Position in IDYA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,165,444
+$587,443 QoQ
Shares Held
111,764
+4.1% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 286 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. IDYA ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in IDYA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,165,444 | 111,764 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,578,001 | 107,383 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,720,596 | 107,625 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,397,195 | 124,851 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,756,751 | 131,149 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,038,278 | 124,437 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,918,517 | 113,561 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,579,079 | 112,976 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,714,532 | 105,797 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,230,470 | 96,410 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,058,670 | 85,966 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,125,862 | 78,794 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,809,077 | 76,982 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $950,267 | 69,211 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,163,497 | 64,034 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $800,875 | 53,678 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $690,096 | 50,007 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $447,398 | 39,982 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $901,795 | 38,147 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $898,777 | 35,260 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $616,497 | 29,371 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $437,288 | 18,608 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $245,266 | 17,519 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $171,695 | 13,670 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $189,646 | 13,346 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||